Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jaśmina Arabska, Aleksandra Margulska, Dominik Strzelecki & Adam Wysokiński. (2019) Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?. Nordic Journal of Psychiatry 73:8, pages 515-521.
Read now
Read now
Yu-Jie Chiou & Tiao-Lai Huang. (2017) Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics. The World Journal of Biological Psychiatry 18:5, pages 382-391.
Read now
Read now
Esra Soydaş Akyol, Yakup Albayrak, Murat Beyazyüz, Nurkan Aksoy, Murat Kuloglu & Kenji Hashimoto. (2015) Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome. Neuropsychiatric Disease and Treatment 11, pages 865-872.
Read now
Read now
Trehani M. Fonseka, Arun K. Tiwari, Vanessa F. Gonçalves, Jeffrey A. Lieberman, Herbert Y. Meltzer, Benjamin I. Goldstein, James L. Kennedy, Sidney H. Kennedy & Daniel J. Müller. (2015) The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain. The World Journal of Biological Psychiatry 16:1, pages 45-56.
Read now
Read now
Articles from other publishers (77)
Ting Cao, ShuangYang Zhang, Qian Chen, CuiRong Zeng, LiWei Wang, ShiMeng Jiao, Hui Chen, BiKui Zhang & HuaLin Cai. (2023) Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways. Schizophrenia Research 260, pages 12-22.
Crossref
Crossref
Tong Zhao, SuFang Tang, XiaoLei Gao, Juan Li, Ran Hao, HaiZhi Chen & GuangBiao Huang. (2023) Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia. International Journal of Methods in Psychiatric Research.
Crossref
Crossref
Andrea Ballesio, Andrea Zagaria, Davide Gusmeo Curti, Rosalyn Moran, Peter J. Goadsby, Ivana Rosenzweig & Caterina Lombardo. (2023) Peripheral brain-derived neurotrophic factor (BDNF) in insomnia: A systematic review and meta-analysis. Sleep Medicine Reviews 67, pages 101738.
Crossref
Crossref
Mirko Manchia, Ulker Isayeva, Roberto Collu, Diego Primavera, Luca Deriu, Edoardo Caboni, Maria Novella Iaselli, Davide Sundas, Massimo Tusconi, Federica Pinna, Pasquale Paribello, Maria Scherma, Claudia Pisanu, Anna Meloni, Clement C. Zai, Donatella Congiu, Alessio Squassina, Walter Fratta, Paola Fadda & Bernardo Carpiniello. (2022) Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders. Brain Sciences 12:12, pages 1666.
Crossref
Crossref
Lin-Jye Huang, Fu-Chang Hu, Chinyu Wu, Yi-Hong Yang, Shu-Chun Lee, Hsu-Chang Huang, Chun-Yi Yu & Kuan-Yu Lai. (2022) Are the measurement structures of the Traditional Chinese Dispositional Flow Scale-2 equivalent between schizophrenic patients and healthy subjects?. Journal of the Formosan Medical Association 121:10, pages 1981-1992.
Crossref
Crossref
Albert Martínez-Pinteño, Gisela Mezquida, Miquel Bioque, Jose M López-Ilundain, Álvaro Andreu-Bernabeu, Iñaki Zorrilla, Anna Mané, Roberto Rodríguez-Jiménez, Iluminada Corripio, Salvador Sarró, Ángela Ibáñez, Judith Usall, Olga Rivero, Patricia Gassó, Juan Carlos Leza, Manuel J Cuesta, Mara Parellada, Ana González-Pinto, Esther Berrocoso, Sergi Mas, Miguel Bernardo, S Amoretti, C Morén, E Urbiola, J González-Peñas, A Roldán, A Catalán, I González-Ortega, A Toll, T Legido, L Sanchez-Pastor, M Dompablo, E Pomarol-Clotet, Landín-Romero R, A Butjosa, E Rubio, Lorente-OmeñacaR, M Ribeiro, I López-Torres, L León-Quismondo, J Nácher, F Contretas, A Lobo, M Gutiérrez-Fraile & PA Sáiz. (2022) The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. European Neuropsychopharmacology 57, pages 105-117.
Crossref
Crossref
Betul Aslan Turkmen, Esra Yazici, Derya Guzel Erdogan, Mehmet Akif Suda & Ahmet Bulent Yazici. (2021) BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia. BMC Psychiatry 21:1.
Crossref
Crossref
Elham Badrlou, Soudeh Ghafouri-Fard, Mir Davood Omrani, Seyedeh Morvarid Neishabouri, Shahram Arsang-Jang, Mohammad Taheri & Farkhondeh Pouresmaeili. (2021) Expression of BDNF-Associated lncRNAs in Treatment-Resistant Schizophrenia Patients. Journal of Molecular Neuroscience 71:11, pages 2249-2259.
Crossref
Crossref
Mariane Nunes Noto, Michael Maes, Sandra Odebrecht Vargas Nunes, Vanessa Kiyomi Ota, Daniel Cavalcante, Giovany Oliveira, Ana C. Rossaneis, Waldiceu A. VerriJr.Jr., Quirino Cordeiro, Sintia Iole Belangero, Ary Gadelha, Cristiano Noto & Rodrigo Affonseca Bressan. (2021) BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system. Journal of Psychiatric Research 141, pages 206-213.
Crossref
Crossref
Lijuan Huo, Zhiwei Zheng, Xiaobing Lu, Fengchun Wu, Yuping Ning & Xiang Yang Zhang. (2021) Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia. Frontiers in Psychiatry 12.
Crossref
Crossref
Magdalena Białoń, Agnieszka Chocyk, Iwona Majcher-Maślanka, Marcelina Żarnowska, Krzysztof Michalski, Lucyna Antkiewicz-Michaluk & Agnieszka Wąsik. (2021) 1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia. Pharmacological Reports 73:2, pages 490-505.
Crossref
Crossref
Shen Li, Dachun Chen, Meihong Xiu, Jie Li & Xiang Yang Zhang. (2021) Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study. Journal of Psychiatric Research 134, pages 39-47.
Crossref
Crossref
Anthony O. Ahmed, Samantha Kramer, Naama Hofman, John Flynn, Marie Hansen, Victoria Martin, Anilkumar Pillai & Peter F. Buckley. (2021) A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels. Neuropsychobiology 80:5, pages 411-424.
Crossref
Crossref
Mehmet Sinan Aydın, Abdullah Bolu, Muhammed Fevzi Kılınçkaya, Taner Öznur, Cemil Çelik, Özcan Uzun & Kamil Nahit Özmenler. (2020)
Brain‐derived
neurotrophic factor levels and psychopathology scores in drug‐naïve first‐episode psychosis
. Asia-Pacific Psychiatry 12:4.
Crossref
Crossref
Jawahar Singh, Rohit Verma, Rahul Raghav, Siddharth Sarkar, Mamta Sood & Raka Jain. (2020) Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study. Asian Journal of Psychiatry 54, pages 102370.
Crossref
Crossref
Yvonne Naegelin, Katharina Saeuberli, Sabine Schaedelin, Hayley Dingsdale, Stefano Magon, Sergio Baranzini, Michael Amann, Katrin Parmar, Charidimos Tsagkas, Pasquale Calabrese, Iris Katharina Penner, Ludwig Kappos & Yves‐Alain Barde. (2020) Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis. Annals of Clinical and Translational Neurology 7:11, pages 2251-2261.
Crossref
Crossref
PVSN Kiran kumar, Prasenjit Mitra, Raghumoy Ghosh, Shailja Sharma, Naresh Nebhinani & Praveen Sharma. (2020) Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia. Behavioural Brain Research 394, pages 112832.
Crossref
Crossref
Samantha Alvarez-Herrera, Raúl Escamilla, Oscar Medina-Contreras, Ricardo Saracco, Yvonne Flores, Gabriela Hurtado-Alvarado, José Luis Maldonado-García, Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez & Lenin Pavón. (2020) Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Frontiers in Endocrinology 11.
Crossref
Crossref
Xiaowei Tang, Chao Zhou, Ju Gao, Weiwei Duan, Miao Yu, Wenhuan Xiao, Xiaobin Zhang, Hui Dong, Xiang Wang & Xiangrong Zhang. (2019) Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. BMC Psychiatry 19:1.
Crossref
Crossref
Adrienne Mary Grech, Xin Du, Simon S. Murray, Junhua Xiao & Rachel Anne Hill. (2019) Sex-specific spatial memory deficits in mice with a conditional TrkB deletion on parvalbumin interneurons. Behavioural Brain Research 372, pages 111984.
Crossref
Crossref
Tomasz Pawełczyk, Marta Grancow-Grabka, Elżbieta Trafalska, Janusz Szemraj, Natalia Żurner & Agnieszka Pawełczyk. (2019) An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial. Psychopharmacology 236:9, pages 2811-2822.
Crossref
Crossref
Monalisa Jena, Rajeev Ranjan, Biswa Ranjan Mishra, Archana Mishra, Santanu Nath, Pallabi Sahu, Bikash Ranjan Meher, Anand Srinivasan & Rituparna Maiti. (2019) Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial. Journal of Psychiatric Research 112, pages 1-6.
Crossref
Crossref
Erifili Hatziagelaki, Anastasia Tsiavou, Charilaos Gerasimou, George Vavougios, Aris Spathis, Efstathios Laskos, Charalabos Papageorgiou, Athanasios Douzenis, Nikos Christodoulou, Nicolaos Stefanis, Demetrios Spandidos, Nikolaos Nikolakakis, Konstantinos Tsamakis & Emmanouil Rizos. (2019) Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis. Experimental and Therapeutic Medicine.
Crossref
Crossref
Madia Lozupone, Maddalena La Montagna, Francesca D’Urso, Antonio Daniele, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Antonello Bellomo & Francesco Panza. 2019. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
135
162
.
Daniela Rodrigues-Amorim, Tania Rivera-Baltanás, João Bessa, Nuno Sousa, María de Carmen Vallejo-Curto, Cynthia Rodríguez-Jamardo, María Elena de las Heras, Roberto Díaz, Roberto Carlos Agís-Balboa, J.M. Olivares & Carlos Spuch. (2018) The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis. Journal of Psychiatric Research 106, pages 43-53.
Crossref
Crossref
Che-Sheng Chu, Dian-Jeng Li, Chin-Liang Chu, Chih-Ching Wu & Ti Lu. (2018) Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment. Psychiatry Investigation 15:7, pages 727-732.
Crossref
Crossref
Alireza Mohammadi, Ehsan Rashidi & Vahid Ghasem Amooeian. (2018) Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Research 265, pages 25-38.
Crossref
Crossref
Anilkumar Pillai, Nina R. Schooler, Diya Peter, Stephen W. Looney, Donald C. Goff, Alexander Kopelowicz, John Lauriello, Theo Manschreck, Alan Mendelowitz, Del D. Miller, Joanne B. Severe, Daniel R. Wilson, Donna Ames, Juan Bustillo, John M. Kane & Peter F. Buckley. (2018) Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?. Schizophrenia Research 193, pages 263-268.
Crossref
Crossref
Abdurrahim Bakirhan, Safak Yalcin Sahiner, Ismail Volkan Sahiner, Yasir Safak & Erol Goka. (2017) Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia. PLOS ONE 12:12, pages e0189373.
Crossref
Crossref
Marta Jóźwiak-Bębenista, Magdalena Jasińska-Stroschein & Edward Kowalczyk. (2017) The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line. Acta Neurobiologiae Experimentalis 77:3, pages 205-213.
Crossref
Crossref
Xingbing Huang, Xiong Huang, Yanling Zhou, Hongbo He, Fang Mei, Bin Sun, Jair C. Soares & Xiang Yang Zhang. (2017) Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population. Psychiatry Research 257, pages 279-283.
Crossref
Crossref
Farhana Islam, Benoit H. Mulsant, Aristotle N. Voineskos & Tarek K. Rajji. (2017) Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia. Current Psychiatry Reports 19:7.
Crossref
Crossref
Reef Einoch, Orly Weinreb, Nina Mandiuk, Moussa B.H. Youdim, Warren Bilker & Henry Silver. (2017) The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. European Neuropsychopharmacology 27:5, pages 470-483.
Crossref
Crossref
Matthieu Sarabi, Aurélie Perraud, Clément Mazouffre, Michelle Nouaille, Marie-Odile Jauberteau & Muriel Mathonnet. (2017) Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patients. Biomedical Reports 6:1, pages 89-94.
Crossref
Crossref
Kenji Sanada, Iñaki Zorrilla, Yusuke Iwata, Cristina Bermúdez-Ampudia, Ariel Graff-Guerrero, Mónica Martínez-Cengotitabengoa & Ana González-Pinto. (2016) The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 17:10, pages 1766.
Crossref
Crossref
Dominik Strzelecki, Olga Kałużyńska & Adam Wysokiński. (2016) BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study). Psychiatry Research 242, pages 54-60.
Crossref
Crossref
Richard M. Kostrzewa, Przemysław Nowak, Ryszard Brus & Russell W. Brown. (2015) Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia. Neurochemical Research 41:1-2, pages 183-192.
Crossref
Crossref
Vidosava B. Djordjević, Dušan Lazarević, Vladan Ćosić, Marinela Z. Knežević, Vidosava B. Djordjević, Ivana Stojanović & Vladimir Djorgevič. (2016) Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric oxide in Patients with Schizophrenia. A pilot study/ Dijagnostička tačnost moždanog neurotrofičkog faktora i azot-monoksida kod obolelih od shizofrenije.Pilot studija. Journal of Medical Biochemistry 35:1, pages 7-16.
Crossref
Crossref
Xiang Yang Zhang, Da-Chun Chen, Yun-Long Tan, Shu-ping Tan, Xingguang Luo, Lingjun Zuo & Jair C. Soares. (2016) BDNF polymorphisms are associated with schizophrenia onset and positive symptoms. Schizophrenia Research 170:1, pages 41-47.
Crossref
Crossref
Xiang Yang Zhang, Yun-Long Tan, Da-Chun Chen, Shu-Ping Tan, Fu-De Yang, Hanjing Emily Wu, Giovana B. Zunta-Soares, Xu-Feng Huang, Thomas R. Kosten & Jair C. Soares. (2016) Interaction of BDNF with cytokines in chronic schizophrenia. Brain, Behavior, and Immunity 51, pages 169-175.
Crossref
Crossref
Hiroshi Nomoto, Hajime Baba, Emi Satomura, Hitoshi Maeshima, Naoko Takebayashi, Yuki Namekawa, Toshihito Suzuki & Heii Arai. (2015) Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry 15:1.
Crossref
Crossref
B S Fernandes, J Steiner, M Berk, M L Molendijk, A Gonzalez-Pinto, C W Turck, P Nardin & C-A Gonçalves. (2014) Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Molecular Psychiatry 20:9, pages 1108-1119.
Crossref
Crossref
A. J. Skilleter, C. S. Weickert, A. Vercammen, R. Lenroot & T. W. Weickert. (2014) Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia. Psychological Medicine 45:4, pages 841-854.
Crossref
Crossref
Russell W. Brown & Daniel J. Peterson. 2016. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology. Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology
387
402
.
Alicia Valiente-Gómez, Benedikt L Amann, Frederic Mármol, Cristina Oliveira, Ana Messeguer, Amalia Lafuente, Edith Pomarol-Clotet & Miguel Bernardo Arroyo. (2014) Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls. Psychiatry Research 220:1-2, pages 197-200.
Crossref
Crossref
Vidhya Renjan, Milawaty Nurjono & Jimmy Lee. (2014) Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia. Psychiatry Research 220:1-2, pages 193-196.
Crossref
Crossref
Trevor Archer, Serafino Ricci, Danilo Garcia & Max Rapp Ricciardi. (2014) Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders. Neurotoxicity Research 26:4, pages 400-413.
Crossref
Crossref
Salih Saygin Eker, Ebru Oztepe Yavasci, Sengul Cangur, Selcuk Kirli & Emre Sarandol. (2014) Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?. Acta Neuropsychiatrica 26:5, pages 291-297.
Crossref
Crossref
Xiang Yang Zhang, Da-Chun Chen, Yun-Long Tan, Shu-ping Tan, Zhi-Ren Wang, Fu-De Yang, Mei-Hong Xiu, Li Hui, Meng-Han Lv, Giovana B. Zunta-Soares & Jair C. Soares. (2014) Gender difference in association of cognition with BDNF in chronic schizophrenia. Psychoneuroendocrinology 48, pages 136-146.
Crossref
Crossref
Błażej Misiak, Dorota Frydecka, Marcin Zawadzki, Maja Krefft & Andrzej Kiejna. (2014) Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept. Neuroscience & Biobehavioral Reviews 45, pages 183-201.
Crossref
Crossref
Roksana Zakharyan & Anna Boyajyan. (2014) Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes. Clinical Biochemistry 47:12, pages 1052-1055.
Crossref
Crossref
Elżbieta Nowakowska, Krzysztof Kus, Piotr Ratajczak, Michał Cichocki & Anna Woźniak. (2014) The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats. Pharmacological Reports 66:3, pages 404-411.
Crossref
Crossref
Emmanouil Rizos, Matilda A. Papathanasiou, Panagiota G. Michalopoulou, Efstathios Laskos, Aggeliki Mazioti, Anastasia Kastania, Konstantina Vasilopoulou, Paraskevi Nikolaidou, Dimitrios Margaritis, Charalabos Papageorgiou & Ioannis Liappas. (2014) A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia. PLoS ONE 9:2, pages e87997.
Crossref
Crossref
Tomihisa Niitsu, Tamaki Ishima, Taisuke Yoshida, Tasuku Hashimoto, Daisuke Matsuzawa, Yukihiko Shirayama, Michiko Nakazato, Eiji Shimizu, Kenji Hashimoto & Masaomi Iyo. (2014) A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Research 215:2, pages 268-273.
Crossref
Crossref
Brendan P. Murphy, Terence Y. Pang, Anthony J. Hannan, Tina-Marie Proffitt, Mirabel McConchie, Melissa Kerr, Connie Markulev, Colin O’Donnell, Patrick D. McGorry & Gregor E. Berger. (2014) Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis. Schizophrenia Research and Treatment 2014, pages 1-10.
Crossref
Crossref
Trevor Archer, Ulla Karilampi, Serafino Ricci & Max Rapp-Ricciardi. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
2181
2205
.
Sonia Ruiz de Azua, Carlos Matute, Laura Stertz, Fernando Mosquera, Aitor Palomino, Iris de la Rosa, Sara Barbeito, Patricia Vega, Flávio Kapczinski & Ana González-Pinto. (2013) Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry 13:1.
Crossref
Crossref
Chirayu D. Pandya, Ammar Kutiyanawalla & Anilkumar Pillai. (2013) BDNF–TrkB signaling and neuroprotection in schizophrenia. Asian Journal of Psychiatry 6:1, pages 22-28.
Crossref
Crossref
Timothy D. Brewerton. (2012) Antipsychotic Agents in the Treatment of Anorexia Nervosa: Neuropsychopharmacologic Rationale and Evidence from Controlled Trials. Current Psychiatry Reports 14:4, pages 398-405.
Crossref
Crossref
Xiang Yang Zhang, Jun Liang, Da Chun Chen, Mei Hong Xiu, Fu De Yang, Therese A. Kosten & Thomas R. Kosten. (2012) Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology 222:2, pages 277-284.
Crossref
Crossref
Reiji Yoshimura, Taro Kishi, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Asuka Katsuki, Kenji Hayashi, Nakao Iwata & Jun Nakamura. (2012) No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients. Clinical Psychopharmacology and Neuroscience 10:1, pages 49-53.
Crossref
Crossref
Pao-Yen Lin. (2012) Increase in Brain-derived Neurotrophic Factor in Patients with Schizophrenia Treated with Olanzapine: A Systemic Review and Meta-analysis. Journal of Experimental & Clinical Medicine 4:2, pages 119-124.
Crossref
Crossref
Gabriela Favalli, Jennifer Li, Paulo Belmonte-de-Abreu, Albert H.C. Wong & Zafiris Jeffrey Daskalakis. (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. Journal of Psychiatric Research 46:1, pages 1-11.
Crossref
Crossref
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Asuka Katsuki, Kenji Hayashi, Kiyokazu Atake, Masaru Tomita & Jun Nakamura. (2012) Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients. Human Psychopharmacology: Clinical and Experimental 27:1, pages 33-38.
Crossref
Crossref
Tomihisa Niitsu, Yukihiko Shirayama, Daisuke Matsuzawa, Tadashi Hasegawa, Nobuhisa Kanahara, Tasuku Hashimoto, Tetsuya Shiraishi, Akihiro Shiina, Goro Fukami, Mihisa Fujisaki, Hiroyuki Watanabe, Michiko Nakazato, Makoto Asano, Sho Kimura, Kenji Hashimoto & Masaomi Iyo. (2011) Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:8, pages 1836-1840.
Crossref
Crossref
Gülfizar Sözeri-Varma, Yaşar Enli, Tuğçe Toker-Uğurlu, Hüseyin Alaçam & Nalan Kalkan-Oğuzhanoğlu. (2011) Decreased serum BDNF levels in major depressive patients. Neurology, Psychiatry and Brain Research 17:4, pages 84-88.
Crossref
Crossref
Emi Satomura, Hajime Baba, Yoshiyuki Nakano, Hitoshi Maeshima, Toshihito Suzuki & Heii Arai. (2011) Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression. Journal of Affective Disorders 135:1-3, pages 332-335.
Crossref
Crossref
Marie-Agnès Costa, Murielle Girard, François Dalmay & Dominique Malauzat. (2011) Brain-Derived Neurotrophic Factor Serum Levels in Alcohol-Dependent Subjects 6 Months After Alcohol Withdrawal. Alcoholism: Clinical and Experimental Research 35:11, pages 1966-1973.
Crossref
Crossref
Chien-Chih Chen & Tiao-Lai Huang. (2011) Effects of antipsychotics on the serum BDNF levels in schizophrenia. Psychiatry Research 189:3, pages 327-330.
Crossref
Crossref
Yan Qiu Yang, Shilong Sun, Ya Qin Yu, Wen Jun Li, Xuan Zhang, Mei Hong Xiu, Da Chun Chen, Fu De Yang, Haibo Liu, Cunbo Li, Thomas R. Kosten & Xiang Yang Zhang. (2011) Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia. Neuroscience Letters 502:1, pages 37-40.
Crossref
Crossref
S. Porcelli, A. Drago, C. Fabbri & A. Serretti. (2011) Mechanisms of antidepressant action: An integrated dopaminergic perspective. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:7, pages 1532-1543.
Crossref
Crossref
E.N. Rizos, M. Papathanasiou, P.G. Michalopoulou, A. Mazioti, A. Douzenis, A. Kastania, P. Nikolaidou, E. Laskos, K. Vasilopoulou & L. Lykouras. (2011) Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophrenia Research 129:2-3, pages 201-204.
Crossref
Crossref
Ah Hyun Lee, Claudia Lange, Roland Ricken, Rainer Hellweg & Undine E. Lang. (2011) Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment. Journal of Clinical Psychopharmacology 31:3, pages 334-336.
Crossref
Crossref
Fabiano R. Agostinho, Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Bianca Pfaffenseller, Laura Stertz, Bruna S. Panizzutti, Flávio Kapczinski & João Quevedo. (2011) Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex. Neuroscience Letters 497:2, pages 99-103.
Crossref
Crossref
Peter F Buckley, Anilkumar Pillai & Kristy R Howell. (2011) Brain-derived neurotrophic factor: findings in schizophrenia. Current Opinion in Psychiatry 24:2, pages 122-127.
Crossref
Crossref
Valerio Ricci, Massimiliano Pomponi, Giovanni Martinotti, Annarita Bentivoglio, Giovanna Loria, Sergio Bernardini, Carlo Caltagirone, Pietro Bria & Francesco Angelucci. (2010) Antidepressant Treatment Restores Brain-Derived Neurotrophic Factor Serum Levels and Ameliorates Motor Function in Parkinson Disease Patients. Journal of Clinical Psychopharmacology 30:6, pages 751-753.
Crossref
Crossref
Xiang Yang Zhang, Mei Hong Xiu, Da Chun Chen, Fu De Yang, Gui Ying Wu, Lin Lu, Therese A. Kosten & Thomas R. Kosten. (2010) Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology 212:3, pages 301-307.
Crossref
Crossref